Da Ben L, Surana Pallavi, Schueler Samuel A, Jalaly Niloofar Y, Kamal Natasha, Taneja Sonia, Vittal Anusha, Gilman Christy L, Heller Theo, Koh Christopher
Digestive Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health Bethesda MD.
Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health Bethesda MD.
Hepatol Commun. 2019 Jul 13;3(9):1271-1280. doi: 10.1002/hep4.1394. eCollection 2019 Sep.
With the success of hepatitis C virus (HCV) direct-acting antiviral therapies, there has been a shift in research focus to the other major chronic liver diseases (CLDs). The use of social media, specifically Twitter, has become a popular platform for understanding public health trends and for performing health care research. To evaluate this, we studied the areas of public interest and social media trends of the following three major CLDs: hepatitis B virus (HBV), HCV, and nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH). Twitter activity data from January 1, 2013, through January 1, 2019, for HBV, HCV, and NAFLD/NASH were collected using the social media analytic tool Symplur Signals (Symplur LLC) software. Content and regression analyses were performed to understand and predict Twitter activity for each of the CLDs. Over the study period, there were 810,980 tweets generating 4,452,939,516 impressions. HCV tweet activity peaked in 2015 at 243,261 tweets, followed by a decline of 52.4% from 2015 to 2016 with a subsequent plateau through 2018. Meanwhile, NAFLD/NASH and HBV tweet activity has continued to increase, with projections that these two CLDs will surpass HCV by the second half of 2023 and 2024, respectively. Treatment and Management was the most popular content category for HCV and NAFLD/NASH, while Prevention was the most popular content category for HBV. Twitter is a useful social media tool to gauge public interest in liver disease over time. The information provided by Twitter can be used to identify gaps in public knowledge or highlight areas of interest that may need further research. Future studies on the use of Twitter in liver disease are warranted.
随着丙型肝炎病毒（HCV）直接抗病毒疗法的成功，研究重点已转向其他主要的慢性肝病（CLD）。社交媒体，特别是推特，已成为了解公共卫生趋势和开展医疗保健研究的热门平台。为对此进行评估，我们研究了以下三种主要慢性肝病的公众关注领域和社交媒体趋势：乙型肝炎病毒（HBV）、HCV以及非酒精性脂肪性肝病（NAFLD）/非酒精性脂肪性肝炎（NASH）。使用社交媒体分析工具Symplur Signals（Symplur有限责任公司）软件收集了2013年1月1日至2019年1月1日期间关于HBV、HCV和NAFLD/NASH的推特活动数据。进行了内容分析和回归分析，以了解和预测每种慢性肝病的推特活动。在研究期间，共有810,980条推文，产生了4,452,939,516次展示量。HCV推文活动在2015年达到峰值，为243,261条推文，随后从2015年到2016年下降了52.4%，并在2018年之前保持平稳。与此同时，NAFLD/NASH和HBV的推文活动持续增加，预计这两种慢性肝病将分别在2023年下半年和2024年超过HCV。“治疗与管理”是HCV和NAFLD/NASH最热门的内容类别，而“预防”是HBV最热门的内容类别。推特是一种有用的社交媒体工具，可长期衡量公众对肝病的兴趣。推特提供的信息可用于识别公众知识方面的差距或突出可能需要进一步研究的感兴趣领域。有必要对推特在肝病中的应用开展未来研究。
